It was reported to boston scientific corporation that an axios stent and electrocautery enhanced delivery system was to be implanted transgastric to the jejunum for the treatment of pancreatic head mass during a gastrojejunostomy procedure performed on (b)(6) 2023.During the procedure, there was difficulty encountered when deploying the stent.The stent eventually fully deployed; however, the first flange did not expand which resulted to the stent moving out of its position.The stent was clipped on each side to mark the location of the puncture.The stent was then removed and the puncture site was closed using resolution clips.Another axios stent was implanted to complete the procedure.There were no patient complications as a result of this event.Note: it was reported that the axios stent was intended to be placed during a gastrojejunostomy procedure.However, per the axios stent and electrocautery-enhanced delivery system instructions for use, the stent is indicated for use to facilitate transgastric or transduodenal endoscopic drainage of symptomatic pancreatic pseudocysts >= 6 cm in size and walled-off necrosis >= 6 cm in size with >= 70% fluid content that are adherent to the gastric or bowel wall.The device is not indicated for placement transgastric to the jejunum.
|